Cervical lymph node dissection for metastatic testicular cancer.

Area of Science:

• Oncology
• Surgical Oncology
• Urologic Oncology

Background:

• Advanced testicular carcinoma often presents with extra-retroperitoneal residual masses requiring resection.
• Cervical metastasis from testicular tumors is uncommon, with limited data on its incidence and management.
• Neck involvement necessitates understanding surgical strategies and follow-up protocols.

Purpose of the Study:

• To investigate the incidence, surgical management, and outcomes of cervical lymph node metastasis in testicular cancer patients.
• To evaluate the safety and efficacy of selective neck dissection for managing neck metastases.
• To identify factors influencing disease recurrence and patient survival.

Main Methods:

• Retrospective review of 665 testicular cancer patients diagnosed between 1997 and 2009.
• Identification and analysis of patients with cervical metastases who underwent surgical therapy.
• Collection of clinical, pathological, treatment, and follow-up data.

Main Results:

• Cervical lymph node metastasis was identified in 26 patients (4%), predominantly in advanced disease stages.
• Nine patients underwent selective neck dissection, six post-chemotherapy and three for late relapse.
• Seven patients achieved disease-free status; two succumbed to disseminated disease.

Conclusions:

• Cervical lymph node metastases from testicular cancer are rare but associated with advanced disease.
• Selective neck dissection is a safe and viable surgical approach for managing these metastases.
• Effective management strategies are crucial for improving outcomes in patients with advanced testicular cancer and neck involvement.